Jupiter Neurosciences Inc
JUNS
Get informed when a big investor buys or sells
+ FollowMarket Cap$3M
Close$
$-3.33
164.4% downside
Current Fair Value
164.4% downsideOvervalued by 164.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.00 Million |
|---|---|
| Enterprise Value | $3.23 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-18.75 |
| Beta | 1.96 |
| Outstanding Shares | 557,567 |
Return
| Return on Equity | 2513.74% |
|---|---|
| Return on Assets | -247.39% |
| Return on Invested Capital | 5907.69% |
Valuation & Multiples
| P/E Ratio | -0.32 |
|---|---|
| PEG | -33.72 |
| Price to Sales | - |
| Price to Book Ratio | -5.18 |
| Enterprise Value to Revenue | 49.97 |
| Enterprise Value to EBIT | -0.34 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.54 |
| Debt to Equity | -4.78 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$-3.75
Average shareholder expectationRevenue Estimate
$400,000
Average shareholder expectationNext Earnings Call
Expected Date
September 2, 2026
EPS Estimate
$-3.75
Average shareholder expectationRevenue Estimate
$400,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 5.40%▲ 3.55% |
|---|---|
| Total Invested | $716,138▲ 9.90% |
| Investors Holding | 10▼ 2.00% |
ESG Score
No data